Septohippocampal network problems linking Down syndrome and Alzheimer's disease

Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology

NIH-funded research New York University School of Medicine · NIH-11456928

Researchers compare mouse models and human brain cells to understand why people with Down syndrome often develop Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11456928 on NIH RePORTER

What this research studies

You would hear that scientists are looking at the specific brain circuits that support memory and attention to learn why these circuits fail in Down syndrome as Alzheimer changes appear. They study a well-known trisomic mouse model (Ts65Dn) to map circuit and cellular problems in the septohippocampal and basocortical networks. The team also grows human neurons from donated skin cells and checks results against donated postmortem human brain tissue. Together these approaches focus on calcium signaling and mitochondrial function as likely causes of network breakdown.

Who could benefit from this research

Good fit: People with Down syndrome (and families who can arrange skin-cell donation) or people with Alzheimer's disease who can donate tissue or cells would be most relevant to contribute samples.

Not a fit: People without Down syndrome or Alzheimer's are unlikely to receive direct benefit from this specific project.

Why it matters

Potential benefit: If successful, this work could point to specific cell processes to target for therapies that slow or prevent Alzheimer's symptoms in people with Down syndrome.

How similar studies have performed: Related mouse-model and human cell studies have revealed Alzheimer-linked changes before, but turning those findings into effective treatments for Down syndrome has not yet been achieved.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.